Related Experiment Video
Updated: Jun 1, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
Mohamed Khateb1, Mai Abu Zant1, Alaa Bsoul1
1Department of Neurology, Rambam Medical Center, Haifa, Israel.
Myasthenia gravis (MG) is linked to a higher risk of extrathymic cancers, especially within five years of diagnosis. This suggests MG may act as a paraneoplastic disorder, warranting further investigation into cancer associations.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Myasthenia gravis (MG) is known to associate with thymic tumors.
- The relationship between MG and extrathymic cancers remains debated.
- Investigating MG as a potential paraneoplastic disorder for extrathymic cancers is crucial.
Purpose of the Study:
- To analyze the association between myasthenia gravis and extrathymic cancers.
- To determine if MG can be considered a paraneoplastic disorder for extrathymic cancers.
- To evaluate cancer rates and associations in a long-term MG cohort.
Main Methods:
- Retrospective analysis of 436 MG patients and 3924 controls over 23 years (2000-2023).
- Extraction of cancer rates, clinical, electrophysiological, and biochemical associations.
- Assessment of the impact of chronic medications on cancer risk.
Main Results:
- MG patients showed significantly higher rates of extrathymic cancers (p < 0.001) compared to controls.
- A relative cancer risk of 2.97 was observed in MG patients compared to rheumatology controls.
- Increased prevalence of extrathymic cancers was noted within the paraneoplastic time window (±5 years).
Conclusions:
- Myasthenia gravis is significantly associated with an increased risk of extrathymic cancers.
- The association is particularly strong within the paraneoplastic time window.
- Findings suggest Myasthenia gravis may function as a paraneoplastic disorder.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Psychoneuroimmunology: Diabetes and Cancer
Cancer Prevention
Some...
The Tumor Microenvironment
Induced Pluripotent Stem Cells
Somatic...

